Home532531 • BOM
add
Strides Pharma Science Ltd
Nakaraang pagsara
₹1,642.00
Sakop ng araw
₹1,595.10 - ₹1,652.55
Sakop ng taon
₹467.40 - ₹1,675.25
Market cap
149.79B INR
Average na Volume
35.70K
P/E ratio
3,338.29
Dividend yield
0.15%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 10.88B | 16.94% |
Gastos sa pagpapatakbo | 4.99B | 13.84% |
Net na kita | 702.02M | 1,086.95% |
Net profit margin | 6.46 | 950.00% |
Kita sa bawat share | — | — |
EBITDA | 2.24B | 33.22% |
Aktuwal na % ng binabayarang buwis | 19.80% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 2.97B | -19.05% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 20.72B | — |
Natitirang share | 91.89M | — |
Presyo para makapag-book | 7.09 | — |
Return on assets | — | — |
Return on capital | 9.17% | — |
Cash Flow
Net change in cash
(INR) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 702.02M | 1,086.95% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Itinatag
1990
Headquarters
Website
Mga Empleyado
3,065